Bergisch Gladbach, Germany

Peter Hahn

This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Qiagen Gmbh. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Hahn. Retrieved from https://idiyas.com/inventor/peter-hahn-jh6p6f5s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 32(Granted Patents)


Location History:

  • Kurten, DE (2012)
  • Bergisch Gladbach, DE (2013 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Hahn

Introduction

Peter Hahn is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of molecular biology, particularly in the development of small interfering nucleic acids (siNAs). With a total of 3 patents to his name, his work has implications for gene silencing and apoptosis research.

Latest Patents

Hahn's latest patents include innovative approaches to modifying siNAs. One of his key inventions is a method that utilizes at least one abasic modification within the first eight nucleotide positions of the 5' region of the antisense strand of a siNA molecule. This modification aims to reduce off-target effects, enhancing the specificity of gene silencing. Additionally, he has developed a positive control for expression modulating experiments, which involves a combination of compounds that silence the expression of target genes involved in apoptosis. This invention provides valuable tools for researchers conducting expression modulating assays.

Career Highlights

Peter Hahn is currently associated with Qiagen GmbH, a leading company in the field of molecular diagnostics and sample preparation. His work at Qiagen has allowed him to focus on advancing technologies that facilitate genetic research and therapeutic applications. His contributions have been instrumental in enhancing the understanding of gene regulation and its applications in medicine.

Collaborations

Hahn has collaborated with esteemed colleagues such as Wolfgang Bielke and Jie Kang. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the scientific community.

Conclusion

Peter Hahn's inventive spirit and dedication to advancing molecular biology have led to significant innovations in the field. His patents reflect a commitment to improving gene silencing techniques and enhancing research methodologies. His work continues to influence the landscape of genetic research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…